Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Detecting DNA methylation of BCL2, CDKN2A and NID2 genes to predict bladder cancer in humans

Detecting DNA methylation of BCL2, CDKN2A and NID2 genes to predict bladder cancer in humans

US Patent 9096905 · Granted Aug 4, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sting agonists for treating bladder cancer and solid tumors2024
Sting agonists for treating bladder cancer and solid tumors2021
ELISA detection of urine DEK to predict and diagnose bladder cancer in humans2020
ELISA detection of urine DEK to predict and diagnose bladder cancer in humans2017
Methods and compositions for detecting and identifying species of Candida2016
ELISA detection of urine DEK to predict and diagnose bladder cancer in humans2016
Oligonucleotides useful in methods for detecting and characterizing Aspergillus 2015
Methods and compositions for detecting serotypes of Chlamydia trachomatis capabl2015
Methods and compositions related thereto for detecting and identifying distinct 2015
Detection of a specific DEK isoform as a urine-based biomarker for bladder cance2014
DEK as a urine based biomarker for bladder cancer2014
Methods and compositions for detecting and identifying species of Candida2013